($) USD (Default)
  • ($) AUD
  • (€) EUR
  • ($) CAD
  • ($) NZD
  • (£) GBP

CJC-1295 DAC Nasal Spray

$40.25$74.25

Peptide CJC-1295 DAC nasal spray demonstrates potential benefits in supporting muscle growth, enhancing fat metabolism, and potentially aiding in the management of age-related hormonal imbalances.

15ml Nasal Spray contains 2mg CJC1295 DAC
30ml Nasal Spray contains 4mg CJC1295 DAC

706 in stock

First time customer gets 15% discount code = 1storder

Buy CJC-1295 DAC Nasal Spray Norway

CJC-1295 DAC nasal spray peptide is a potent growth hormone releasing peptide that has significant impacts on the human body. It is comprised of 30 amino acids and is categorised as tetrasubstituted peptide hormone.

CJC-1295 DAC peptide is an improved version of GRF (1-29) with a modified half-life. Both humans and animals can experience an increase in insulin-like growth factor 1 (IGF-1) and plasma growth hormone (GH).

DAC, or Drug Affinity Complex, is a technology that enhances the half-life and effectiveness of peptides like CJC-1295. It modifies the peptide’s structure for increased stability and slower degradation, allowing for a longer active period in the bloodstream. This results in consistent and prolonged effects, making DAC a valuable tool for research in growth hormone secretion, metabolic regulation, and other hormonal functions.

The use of DAC in the nasal spray formulation facilitates rapid absorption through the nasal mucosa, leading to quicker onset of action. This innovative approach not only simplifies the administration process but also potentially increases patient compliance in research settings focused on hormonal regulation and other health outcomes.

One of the significant advantages of the nasal spray is its ability to bypass the digestive system, which can degrade peptides when taken orally. This ensures a more efficient absorption into the bloodstream, facilitating quicker onset of effects and heightened research outcomes. The nasal route also minimizes discomfort and the need for sterile injection techniques, thus simplifying the research process.

Explore the complete collection of CJC-1295 with DAC peptides and uncover their key benefits by visiting the primary CJC-1295 DAC category page at Direct Sarms Norway online.


CJC-1295 DAC Nasal Spray Benefits Norway

  • Non-Invasive Delivery: Similar to other nasal sprays, CJC-1295 DAC offers a convenient, non-invasive alternative to injections, allowing for easy self-administration and increased participant comfort in clinical studies.
  • Extended Half-Life: The DAC (Drug Affinity Complex) modification helps prolong the half-life of CJC-1295, ensuring a sustained release of growth hormone-releasing hormone (GHRH), leading to longer-lasting physiological effects compared to traditional formulations.
  • Enhanced Growth Hormone Secretion: CJC-1295 DAC stimulates the release of growth hormone from the pituitary gland, which can promote increased muscle mass, improved recovery, and enhanced fat loss, making it ideal for research on gh production and body composition.
  • Faster Onset of Action: The nasal spray formulation allows for rapid absorption through the nasal mucosa, facilitating quicker physiological responses and enabling researchers to observe immediate data relevant to growth hormone dynamics.
  • Improved Sleep and Recovery: Test subjects often report better sleep quality and energy levels, which are crucial for optimal recovery and hormonal balance, making it beneficial for studies focused on health improvement.
  • Support for Metabolic Health: CJC-1295 DAC has the potential to aid in metabolic health by promoting beneficial changes in body composition, improving insulin sensitivity, and supporting overall metabolic processes, valuable in research related to obesity and metabolic syndrome.

Explore our extensive range of peptide nasal sprays available for purchase online at Direct SARMs Norway today.


References:

[1] M Alba, D Fintini, A Sagazio, B Lawrence, JP Castaigne, L A Frohman, R Salvatori (2006) Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse – American Journal of Physiology. Endocrinology and Metabolism, 2006 Dec, Volume 291 (Issue 6), Pages E1290-4.


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Norway Direct Sarms website is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.

Related Products

You may also like…